The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Eli Lilly and Co.
MarketBeat on MSN1d
Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are CrucialDetailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this ...
Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
This innovative program addresses global health initiatives and medical training in Peru with Partners in Health, known ...
Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
In a recent Tech Talk X webinar, we explored the broader implications and what comes next. OpenAI’s closed-model strategy, ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback